These studies all demonstrate the sufficiency of prostate cancer cell lines to secrete BMPs to promote an osteogenic program, yet inhibition of BMP may require further coordination of additional signaling pathways.48 The gene discussed is CLN5; the disease is Familial prostate cancer.